Treatment Updates in Advanced Thymoma and Thymic Carcinoma

被引:15
作者
Gubens, Matthew A. [1 ]
机构
[1] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, Thorac Oncol Program, San Francisco, CA 94115 USA
关键词
Thymoma; Thymic carcinoma; Thymic malignancies; GROWTH-FACTOR RECEPTOR; PHASE-II; EPITHELIAL TUMORS; MALIGNANT THYMOMA; INTERGROUP TRIAL; INVASIVE THYMOMA; CHEMOTHERAPY; CISPLATIN; RECURRENT; GENE;
D O I
10.1007/s11864-012-0211-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Thymomas and thymic carcinomas are rare diseases of the anterior mediastinum. Although some thymomas are quite indolent and able to be resected in a curative fashion, the treatment of metastatic disease remains a challenge, especially for the more aggressive thymic carcinoma histology. Based on the results of single-arm trials, combination chemotherapy is the standard of care in the first-line, and anthracycline-based treatments should be used if patients are reasonably fit. Several single-agent cytotoxic chemotherapy agents have some effectiveness in subsequent lines of therapy, especially pemetrexed and, in octreotide scan-positive patients, octreotide. Prospective trials of new agents are difficult to conduct given the rarity of thymoma, but various targeted therapies do show promise. Greater international research collaboration, as well as modern techniques in molecular and genomic characterization, should help to advance the treatment of thymic malignancies in the near future.
引用
收藏
页码:527 / 534
页数:8
相关论文
共 41 条
[1]   A phase II trial of erlotinib plus bevacizumab in patients with recurrent thymoma or thymic carcinoma [J].
Bedano, P. M. ;
Perkins, S. ;
Burns, M. ;
Kessler, K. ;
Nelson, R. ;
Schneider, B. P. ;
Risley, L. ;
Dropcho, S. ;
Loehrer, P. J. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[2]   The Biologic Spectrum of Thymic Epithelial Neoplasms: Current Status and Future Prospects [J].
Cheney, Richard T. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2010, 8 (11) :1322-1328
[3]   International Thymic Malignancies Interest Group A Way Forward [J].
Detterbeck, Frank .
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 :S365-S370
[4]   Overview [J].
Detterbeck, Frank C. ;
Huang, James .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (07) :S1689-S1690
[5]   Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies [J].
Engels, EA ;
Pfeiffer, RM .
INTERNATIONAL JOURNAL OF CANCER, 2003, 105 (04) :546-551
[6]   Thymic Malignancies [J].
Ettinger, David S. ;
Akerley, Wallace ;
Bepler, Gerold ;
Blum, Matthew G. ;
Chang, Andrew ;
Cheney, Richard T. ;
Chineac, Lucian R. ;
Amico, Thomas A. D. ;
Demmy, Todd L. ;
Govindan, Ramaswamy ;
Grannis, Frederic W., Jr. ;
Jahan, Thierry ;
Johnson, David H. ;
Kessinger, Anne ;
Komaki, Ritsuko ;
Kong, Feng-Ming ;
Kris, Mark G. ;
Krug, Lee M. ;
Le, Quynh Thu ;
Lennes, Inga T. ;
Martins, Renato ;
Malley, Janis O. ;
Osarogiagbon, Raymond U. ;
Otterson, Gregory A. ;
Patel, Jyoti D. ;
Pisters, Katherine M. ;
Reckamp, Karen ;
Riely, Gregory J. ;
Rohren, Eric ;
Swanson, Scott J. ;
Wood, Douglas E. ;
Yang, Stephen C. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2010, 8 (11) :1302-1315
[7]  
FORNASIERO A, 1991, CANCER, V68, P30, DOI 10.1002/1097-0142(19910701)68:1<30::AID-CNCR2820680106>3.0.CO
[8]  
2-4
[9]   Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma: A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group [J].
Giaccone, G ;
Ardizzoni, A ;
Kirkpatrick, A ;
Clerico, M ;
Sahmoud, T ;
vanZandwijk, N .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :814-820
[10]   Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors [J].
Giaccone, Giuseppe ;
Rajan, Arun ;
Berman, Arlene ;
Kelly, Ronan J. ;
Szabo, Eva ;
Lopez-Chavez, Ariel ;
Trepel, Jane ;
Lee, Min-Jung ;
Cao, Liang ;
Espinoza-Delgado, Igor ;
Spittler, John ;
Loehrer, Patrick J., Sr. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) :2052-2059